Dikou Maria, Xanthos Theodoros, Dimitropoulos Ioannis, Iliodromiti Zoi, Sokou Rozeta, Kafalidis Georgios, Boutsikou Theodora, Iacovidou Nicoletta
Department of Neonatology, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
Medical School, European University Cyprus, Nicosia 2404, Cyprus.
Diagnostics (Basel). 2022 Apr 1;12(4):881. doi: 10.3390/diagnostics12040881.
The aim of this systematic review and meta-analysis is the comparison of endotracheal intubation and suctioning to immediate resuscitation without intubation of non-vigorous infants > 34 weeks’ gestation delivered through meconium-stained amniotic fluid (MSAF). Randomized, non-randomized clinical trials and observational studies were included. Data sources were PubMed/Medline and Cochrane Central Registry of Controlled Trials, from 2012 to 2021. Inclusion criteria were non-vigorous infants born through MSAF with gestational age > 34 weeks and sample size ≥ 5. We calculated overall relative risks (RR) and mean differences (MD) with a 95% confidence interval (CI) to determine the impact of endotracheal suction (ETS) in non-vigorous infants born through MSAF. The outcomes presented are the incidence of neonatal mortality, meconium aspiration syndrome (MAS), transient tachypnea, need for positive pressure ventilation, respiratory support, persistent pulmonary hypertension treatment, neonatal infection, ischemic encephalopathy, admission to neonatal intensive care unit (NICU) and the duration of hospitalization between ETS and non-ETS group. Six studies with a total sample of 1026 patients fulfilled the inclusion criteria. Statistically non-significant difference was observed in RR between two groups with regards to mortality (1.22, 95% CI 0.73−2.04), occurrence of MAS (1.08, 95% CI 0.76−1.53) and other outcomes, and MD in hospitalization duration. There is no sufficient evidence to suggest initiating endotracheal suction soon after birth in non-vigorous meconium-stained infants as routine.
本系统评价和荟萃分析的目的是比较气管插管及吸引与对胎粪污染羊水(MSAF)分娩的孕龄>34周、无活力婴儿立即进行不插管复苏的效果。纳入了随机、非随机临床试验和观察性研究。数据来源为2012年至2021年的PubMed/Medline和Cochrane对照试验中央注册库。纳入标准为通过MSAF分娩的无活力婴儿,孕龄>34周,样本量≥5。我们计算了总体相对风险(RR)和平均差(MD)及95%置信区间(CI),以确定气管内吸引(ETS)对通过MSAF分娩的无活力婴儿的影响。呈现的结果是新生儿死亡率、胎粪吸入综合征(MAS)、短暂性呼吸急促、需要正压通气、呼吸支持、持续性肺动脉高压治疗、新生儿感染、缺血性脑病、入住新生儿重症监护病房(NICU)的发生率以及ETS组和非ETS组之间的住院时间。六项共1026例患者的研究符合纳入标准。两组在死亡率(1.22,95%CI 0.73−2.04)、MAS发生率(1.08,95%CI 0.76−1.53)及其他结果方面的RR,以及住院时间的MD,差异均无统计学意义。没有足够的证据表明,对出生后无活力、胎粪污染的婴儿常规尽早进行气管内吸引是必要的。